Terms: = Ovarian cancer AND BCL9, LGS, 607, ENSG00000116128, MGC131591 AND Prognosis
10 results:
1. Impact of Oophorectomy on Survival and Improving Nutritional Status in ovarian Metastasis from Colorectal Adenocarcinoma.
Miyagawa Y; Kitazawa M; Tokumaru S; Nakamura S; Koyama M; Yamamoto Y; Miyazaki S; Hondo N; Soejima Y
Oncology; 2024; 102(2):114-121. PubMed ID: 37699374
[TBL] [Abstract] [Full Text] [Related]
2. Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: A meta-analysis.
Kim SI; Kim JH; Lee S; Cho H; van Driel WJ; Sonke GS; Bristow RE; Park SY; Fotopoulou C; Lim MC
Gynecol Oncol; 2022 Dec; 167(3):547-556. PubMed ID: 36273925
[TBL] [Abstract] [Full Text] [Related]
3. Increased expression of plakophilin 3 is associated with poor prognosis in ovarian cancer.
Qian H; Yuan D; Bao J; Liu F; Zhang W; Yang X; Han G; Huang J; Sheng H; Yu H
Medicine (Baltimore); 2019 Mar; 98(10):e14608. PubMed ID: 30855445
[TBL] [Abstract] [Full Text] [Related]
4. Postoperative chemotherapy had no prognostic effect on early-staged young ovarian cancer with unilateral resection.
Zhang X; Wang S; Zhao S; Sun Y; Yang G
Cancer Med; 2018 Nov; 7(11):5488-5496. PubMed ID: 30306725
[TBL] [Abstract] [Full Text] [Related]
5. Nerve growth factor modulates the tumor cells migration in ovarian cancer through the WNT/β-catenin pathway.
Li B; Cai S; Zhao Y; He Q; Yu X; Cheng L; Zhang Y; Hu X; Ke M; Chen S; Zou M
Oncotarget; 2016 Dec; 7(49):81026-81048. PubMed ID: 27835587
[TBL] [Abstract] [Full Text] [Related]
6. Preoperative multiplication of neutrophil and monocyte counts as a prognostic factor in epithelial ovarian cancer.
Paik ES; Shim M; Choi HJ; Lee YY; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS
Cancer Biomark; 2016; 17(4):419-425. PubMed ID: 27802193
[TBL] [Abstract] [Full Text] [Related]
7. The Influence of Cyst Emptying, Lymph Node Resection and Chemotherapy on Survival in Stage IA and IC1 Epithelial ovarian cancer.
Rosendahl M; Mosgaard BJ; Høgdall C
Anticancer Res; 2016 Oct; 36(10):5373-5379. PubMed ID: 27798901
[TBL] [Abstract] [Full Text] [Related]
8. Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients.
Bakrin N; Bereder JM; Decullier E; Classe JM; Msika S; Lorimier G; Abboud K; Meeus P; Ferron G; Quenet F; Marchal F; Gouy S; Morice P; Pomel C; Pocard M; Guyon F; Porcheron J; Glehen O;
Eur J Surg Oncol; 2013 Dec; 39(12):1435-43. PubMed ID: 24209430
[TBL] [Abstract] [Full Text] [Related]
9. BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer.
Grisham RN; Iyer G; Garg K; Delair D; Hyman DM; Zhou Q; Iasonos A; Berger MF; Dao F; Spriggs DR; Levine DA; Aghajanian C; Solit DB
Cancer; 2013 Feb; 119(3):548-554. PubMed ID: 22930283
[TBL] [Abstract] [Full Text] [Related]
10. WT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study.
Netinatsunthorn W; Hanprasertpong J; Dechsukhum C; Leetanaporn R; Geater A
BMC Cancer; 2006 Apr; 6():90. PubMed ID: 16606472
[TBL] [Abstract] [Full Text] [Related]
